Description

5-Amino-1MQ – 5mg

(Small Molecule Research Compound – NNMT Inhibitor)

5-Amino-1MQ is a small molecule analog studied as a selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular energy metabolism and methylation pathways. NNMT plays a regulatory role in NAD+ availability, energy expenditure, and adiposity. By inhibiting NNMT, 5-Amino-1MQ has been investigated for its potential to modulate metabolic processes, support mitochondrial efficiency, and influence lipid and glucose regulation in research models.

Research studies have focused on its effects on energy balance, obesity-related mechanisms, and age-associated metabolic decline.

---

Mechanism of Action (Based on Preclinical and Experimental Research):

• Inhibits NNMT, reducing methylation of nicotinamide

• Preserves NAD+ availability and enhances cellular energy metabolism

• Promotes increased SIRT1 activity, supporting mitochondrial function

• Modulates adipogenesis and lipid metabolism pathways

---

Potential Benefits (Based on Preclinical Research):

• Studied for reductions in fat mass and improvements in body composition

• Investigated for enhancement of energy expenditure and metabolic rate

• Explored in models of glucose regulation and insulin sensitivity

• Potential neuroprotective and anti-aging implications through NAD+ and SIRT1 pathways

---

For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory agency and is intended solely for laboratory research.